ArticleScientific reports2026

RETN and BMP2 as potential biomarkers for prognosis and immune landscape in lung squamous cell carcinoma: from bioinformatics to clinical validation.

Juan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.